A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients

Catharina M. Korse(The Netherlands Cancer Institute), Huub H. van Rossum(The Netherlands Cancer Institute), Theodora C. Linders(The Netherlands Cancer Institute), Daan van den Broek(The Netherlands Cancer Institute), Johanna C.G.M. Buning-Kager(The Netherlands Cancer Institute), Margot Tesselaar(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Annemieke C. Heijboer(Vrije Universiteit Amsterdam), Olaf van Tellingen(Dutch Cancer Society)
Clinica Chimica Acta
April 4, 2017
10.1016/j.cca.2017.04.001
Cited by 23

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688